0
Your cart

Your cart is empty

Books > Medicine > Other branches of medicine > Pharmacology

Buy Now

New Targets for the Treatment of Hypertension and Associated Diseases, Volume 94 (Hardcover) Loot Price: R5,408
Discovery Miles 54 080
New Targets for the Treatment of Hypertension and Associated Diseases, Volume 94 (Hardcover): William B. Campbell, John D. Imig

New Targets for the Treatment of Hypertension and Associated Diseases, Volume 94 (Hardcover)

William B. Campbell, John D. Imig

Series: Advances in Pharmacology

 (sign in to rate)
Loot Price R5,408 Discovery Miles 54 080 | Repayment Terms: R507 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

New Targets for the Treatment of Hypertension and Associated Diseases, Volume 94 in the Advances in Pharmacology serial, highlights new advances in the field, with this new volume presenting interesting chapters on Cytochrome P450, 20-hydroxyeicosatetraenoic acid and GPR75 pathway in hypertension, Treatment of hypertension with soluble epoxide hydrolase inhibitors, Effects of allosteric modifiers of adenosine receptors in the heart, Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury, Drugs affecting the nitric oxide- cyclic GMP pathway in hypertension, Relaxin-2 and Serelaxin in renal and cardiac dysfunction in hypertension, and more.

General

Imprint: Academic Press Inc
Country of origin: United Kingdom
Series: Advances in Pharmacology
Release date: June 2022
First published: 2022
Volume editors: William B. Campbell • John D. Imig
Dimensions: 229 x 152mm (L x W)
Format: Hardcover
Pages: 420
ISBN-13: 978-0-323-91087-3
Categories: Books > Medicine > Other branches of medicine > Pharmacology > General
LSN: 0-323-91087-4
Barcode: 9780323910873

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners